EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic impact of low BMI on outcomes following definitive radiotherapy for esophageal squamous cell carcinoma

Jian Wang, Junhui Wang, Jianxin Chen

Frontiers in Nutrition · 17.06.2026 · 13

DOI: 10.3389/fnut.2026.1774890 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 17.06.2026. Verfasst von Jian Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Education, Department of International Ward, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Qu…. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Esophageal squamous cell carcinoma (ESCC) is a globally significant malignancy with a poor prognosis. While definitive radiotherapy is a primary curative-intent treatment for early-to-mid-stage ESCC, patient outcomes remain heterogeneous. Nutritional status, as reflected by body mass index (BMI), is increasingly recognized as a critical host-related factor influencing cancer prognosis. However, evidence regarding the impact of low BMI on survival and treatment-related toxicity in ESCC patients treated with radiotherapy remains limited.

Methods

This retrospective, single-center cohort study analyzed 135 patients with stage I–III ESCC who received definitive radiotherapy between 2021 and 2024. Patients were stratified into low BMI (<18.5 kg/m 2 , n = 33) and non-low BMI (≥18.5 kg/m 2 , n = 102) groups based on WHO criteria. Baseline characteristics, laboratory parameters, and treatment details were collected. Survival outcomes (overall survival [OS] and progression-free survival [PFS]) were evaluated using Kaplan–Meier analysis and Cox regression models to identify independent prognostic factors. Treatment-related adverse events (AEs) were graded per CTCAE v5.0.

Results

The low BMI group had a significantly higher proportion of advanced TNM stage III disease (78.8% vs. 49.0%, p = 0.011) and nutritional risk (NRS2002 ≥ 3: 93.9% vs. 72.5%, p = 0.010). With a median follow-up of 24.5 months, the low BMI group exhibited markedly inferior median OS (16.60 vs. 38.30 months, p = 0.010), though PFS did not differ significantly (11.60 vs. 19.80 months, p = 0.106), despite a numerical trend toward worse PFS in the low BMI group. Multivariate analysis identified nutritional risk (HR = 2.100, p = 0.047) as an independent predictor of OS. The low BMI group also showed numerically higher rates of hematological and non-hematological toxicities, including severe anemia (12.1% vs. 2.9%) and radiation esophagitis (75.7% vs. 50.0%).

Conclusion

Low baseline body mass index (BMI) was associated with inferior unadjusted overall survival and a numerically higher burden of treatment-related toxicity in ESCC patients undergoing definitive radiotherapy. However, after accounting for TNM stage and NRS2002-defined nutritional risk, BMI did not remain an independent prognostic factor. These findings suggest that BMI should be interpreted as a simple surrogate marker of nutritional vulnerability and adverse baseline clinical status. Comprehensive nutritional assessment and early supportive intervention should be integrated into multidisciplinary management for this vulnerable population.

Schlagwörter

Stichwörter der Autor:innen

body mass indexesophageal squamous cell carcinomaradiotherapysurvivaltreatment-related toxicity

Autor:innen und Institutionen

  • Department of Education, Department of International Ward, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, Zhejiang, China.
  • Department of Gastroenterology, Jiaxing Second Hospital, Jiaxing, Zhejiang, China.
  • Department of Radiation, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, Zhejiang, China.
  • School of Medicine, Shaoxing University, Shaoxing, Zhejiang, China.

Zitieren

APA

Wang, J., Wang, J., & Chen, J. (2026). Prognostic impact of low BMI on outcomes following definitive radiotherapy for esophageal squamous cell carcinoma. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1774890

Vancouver

Wang J, Wang J, Chen J. Prognostic impact of low BMI on outcomes following definitive radiotherapy for esophageal squamous cell carcinoma. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1774890

BibTeX
@article{Wang2026,
  author = {Wang, Jian and Wang, Junhui and Chen, Jianxin},
  title = {Prognostic impact of low BMI on outcomes following definitive radiotherapy for esophageal squamous cell carcinoma},
  journal = {Frontiers in Nutrition},
  year = {2026},
  volume = {13},
  doi = {10.3389/fnut.2026.1774890}
}
Kostenlos starten →